Evidence map›Paper›PMID 21471200›Full record

ArticleThe Journal of biological chemistry2011

Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts.

Shengyong Yang, Haiyan Xu, Shibing Yu, Huiling Cao, Jie Fan, Chunxi Ge, Renny T Fransceschi, Henry H Dong, Guozhi Xiao

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Forkhead box O proteins: steering the course of stem cell fate.Cell regeneration (London, England) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. The Development of Molecular Biology of Osteoporosis.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Shengyong YangDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15240, USA.
Haiyan Xu
Shibing Yu
Huiling Cao
Jie Fan
Chunxi Ge
Renny T Fransceschi
Henry H Dong
Guozhi Xiao
University of Pittsburgh · USUniversity of Michigan–Ann Arbor · USChongqing Medical University · CNRhode Island Hospital · US

Funding

Role of ATF-4 in the Anabolic Actions of PTH on BoneR01DK072230 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIAO, GUOZHI · 2007 to 2011
$1.4M
Foxo1 in Triglyceride MetabolismR01DK066301 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONG, HENGJIANG HENRY · 2006 to 2010
$1.3M
ATF4 and OsteoclastogenesisR01AR059647 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIAO, GUOZHI · 2010 to 2013
$991k
NIAMS NIH HHS AR059647NIAMS NIH HHS R01 AR059647NIDDK NIH HHS DK066301NIDDK NIH HHS DK072230NIDDK NIH HHS R01 DK066301NIDDK NIH HHS R01 DK072230
6 · The paper itself

Abstract

In this study, we determined the molecular mechanisms whereby forkhead transcription factor Foxo1, a key downstream signaling molecule of insulin-like growth factor 1 (IGF1)/insulin actions, regulates Runx2 activity and expression of the mouse osteocalcin gene 2 (Bglap2) in osteoblasts in vitro. We showed that Foxo1 inhibited Runx2-dependent transcriptional activity and osteocalcin mRNA expression and Bglap2 promoter activity in MC-4 preosteoblasts. Co-immunoprecipitation assay showed that Foxo1 physically interacted with Runx2 via its C-terminal region in osteoblasts or when co-expressed in COS-7 cells. Electrophoretic mobility shift assay demonstrated that Foxo1 suppressed Runx2 binding to its cognate site within the Bglap2 promoter. IGF1 and insulin prevented Foxo1 from inhibiting Runx2 activity by promoting Foxo1 phosphorylation and nuclear exclusion. In contrast, a neutralizing anti-IGF1 antibody decreased Runx2 activity and osteocalcin expression in osteoblasts. Chromatin immunoprecipitation assay revealed that IGF1 increased Runx2 interaction with a chromatin fragment of the proximal Bglap2 promoter in a PI3K/AKT-dependent manner. Conversely, knockdown of Foxo1 increased Runx2 interaction with the promoter. This study establishes that Foxo1 is a novel negative regulator of osteoblast-specific transcription factor Runx2 and modulates IGF1/insulin-dependent regulation of osteocalcin expression in osteoblasts.

Indexed as

Active Transport, Cell NucleusAnimalsCell LineCell NucleusChlorocebus aethiopsChromatinCore Binding Factor Alpha 1 SubunitCOS CellsForkhead Box Protein O1Forkhead Transcription FactorsGene Expression RegulationInsulinInsulin-Like Growth Factor IMiceOsteoblastsOsteocalcinChromatinCore Binding Factor Alpha 1 SubunitForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseInsulinInsulin-Like Growth Factor IOsteocalcinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, MessengerRunx2 protein, mouse

Identifiers

PMID21471200
PMCPMC3099728
OpenAlexW2130434604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.